JP2024515770A5 - - Google Patents
Info
- Publication number
- JP2024515770A5 JP2024515770A5 JP2023565586A JP2023565586A JP2024515770A5 JP 2024515770 A5 JP2024515770 A5 JP 2024515770A5 JP 2023565586 A JP2023565586 A JP 2023565586A JP 2023565586 A JP2023565586 A JP 2023565586A JP 2024515770 A5 JP2024515770 A5 JP 2024515770A5
- Authority
- JP
- Japan
- Prior art keywords
- benzoxazole
- dichlorophenyl
- carboxylic acid
- crystalline
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21382362.8 | 2021-04-26 | ||
| EP21382362.8A EP4083027A1 (en) | 2021-04-26 | 2021-04-26 | A solid state form of tafamidis and a process for its preparation |
| PCT/EP2022/060716 WO2022229026A1 (en) | 2021-04-26 | 2022-04-22 | A solid state form of tafamidis and a process for its preparation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024515770A JP2024515770A (ja) | 2024-04-10 |
| JP2024515770A5 true JP2024515770A5 (cg-RX-API-DMAC10.html) | 2025-03-10 |
| JP7881608B2 JP7881608B2 (ja) | 2026-06-29 |
Family
ID=75746555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023565586A Active JP7881608B2 (ja) | 2021-04-26 | 2022-04-22 | タファミジスの固体形態及びその製造方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240208915A1 (cg-RX-API-DMAC10.html) |
| EP (2) | EP4083027A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7881608B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN117255781A (cg-RX-API-DMAC10.html) |
| BR (1) | BR112023022116A2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3216325A1 (cg-RX-API-DMAC10.html) |
| MX (1) | MX2023012460A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022229026A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023091534A1 (en) * | 2021-11-17 | 2023-05-25 | Teva Pharmaceuticals International Gmbh | Solid state form of tafamidis |
| WO2026159144A1 (en) | 2025-01-22 | 2026-07-30 | Inke, S.A. | Solid forms of tafamidis methyl ethyl ketone solvate and processes for their manufacture |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1587821T6 (da) | 2002-12-19 | 2025-05-26 | Scripps Research Inst | Sammensætninger og fremgangsmåder til stabilisering af trans-thyretin og inhibering af transthyretin-fejlfoldning |
| KR20130079353A (ko) * | 2010-04-21 | 2013-07-10 | 키에시 파르마슈티시 엣스. 피. 에이. | 트랜스티레틴 아밀로이드증 치료용 1-(2-플루오로비페닐-4-일)-알킬 카복실산 유도체 |
| WO2013038351A1 (en) | 2011-09-16 | 2013-03-21 | Pfizer Inc. | Solid forms of a transthyretin dissociation inhibitor |
| HUE056583T2 (hu) | 2014-09-08 | 2022-02-28 | Pfizer | 6-Karboxi-2-(3,5-diklórfenil)-benzoxazol kristályos szilárd formái |
| GB2571950A (en) | 2018-03-13 | 2019-09-18 | Azad Pharma Ag | New polymorph and new path to synthesize tafamidis |
| HRP20250159T1 (hr) | 2019-05-16 | 2025-03-28 | Assia Chemical Industries Ltd. | Kruti oblici tafamidisa i njegovih soli |
| WO2021001858A1 (en) * | 2019-07-04 | 2021-01-07 | Msn Laboratories Private Limited, R&D Center | Improved process for the preparation of 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid or its pharmaceutically acceptable salts and polymorphs thereof |
| WO2021019448A1 (en) | 2019-08-01 | 2021-02-04 | Honour (R&D) | Process for the preparation of transthyretin dissociation inhibitor |
| WO2021152623A1 (en) * | 2020-01-27 | 2021-08-05 | Dr. Reddy’S Laboratories Limited | Improved processes for the preparation of tafamidis and its meglumine salt |
| WO2022084790A1 (en) * | 2020-10-19 | 2022-04-28 | Glenmark Life Sciences Limited | Process for preparation of tafamidis and salts thereof |
-
2021
- 2021-04-26 EP EP21382362.8A patent/EP4083027A1/en not_active Withdrawn
-
2022
- 2022-04-22 WO PCT/EP2022/060716 patent/WO2022229026A1/en not_active Ceased
- 2022-04-22 US US18/288,195 patent/US20240208915A1/en active Pending
- 2022-04-22 EP EP22724736.8A patent/EP4330237A1/en active Pending
- 2022-04-22 CA CA3216325A patent/CA3216325A1/en active Pending
- 2022-04-22 JP JP2023565586A patent/JP7881608B2/ja active Active
- 2022-04-22 CN CN202280030391.4A patent/CN117255781A/zh active Pending
- 2022-04-22 BR BR112023022116A patent/BR112023022116A2/pt unknown
- 2022-04-22 MX MX2023012460A patent/MX2023012460A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI847144B (zh) | 奧美卡替莫卡必爾的合成 | |
| JP2023519891A5 (cg-RX-API-DMAC10.html) | ||
| JP2005503386A5 (cg-RX-API-DMAC10.html) | ||
| JP2015107976A (ja) | 結晶形態のテノホビルジソプロキシル及びその製造方法 | |
| EP1296951A1 (en) | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis | |
| AU2001264804A1 (en) | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis | |
| JP2024537795A5 (cg-RX-API-DMAC10.html) | ||
| JP2009521414A5 (cg-RX-API-DMAC10.html) | ||
| JP2024521412A5 (cg-RX-API-DMAC10.html) | ||
| JP2024095561A5 (cg-RX-API-DMAC10.html) | ||
| JP2025148397A5 (cg-RX-API-DMAC10.html) | ||
| JP2022542803A5 (cg-RX-API-DMAC10.html) | ||
| JP2024514090A5 (cg-RX-API-DMAC10.html) | ||
| JP6068569B2 (ja) | シロドシンの製造方法および中間体 | |
| CZ1494A3 (en) | Process for preparing diphenyl derivatives, aromatic compound and its use | |
| CN108484567B (zh) | 一种1-氟-1,3-丙烷磺酸内酯的制备方法 | |
| JP2022540678A5 (cg-RX-API-DMAC10.html) | ||
| JP2016510767A5 (cg-RX-API-DMAC10.html) | ||
| CA2447878C (en) | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis | |
| JPS61167673A (ja) | (イソキサゾール‐3‐イル)アリールメタノンおよびその製造方法 | |
| JP2023530785A5 (cg-RX-API-DMAC10.html) | ||
| EP2385046B1 (fr) | Phase précurseur et son utilisation pour préparer le sel de magnésium tétrahydraté d'un énantiomère d'oméprazole | |
| JP5485138B2 (ja) | エチニルチミジン化合物の精製方法 | |
| JP2024529763A5 (cg-RX-API-DMAC10.html) | ||
| WO2016202252A1 (zh) | 一种合成d-对羟基苯甘氨酸甲酯的方法 |